Biologics Market Report 2025-2035

The Biologics Market Report 2025-2035: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Escalating Demand for Biologics is Boosting the Market Growth

The escalating demand for biologics continues to be a significant driver of growth in the pharmaceutical market as of 2025. Biologics–therapies derived from living organisms–are renowned for their precision in targeting specific molecules or cells, leading to effective treatments with reduced side effects. This precision makes them particularly valuable in addressing complex medical conditions such as cancer, autoimmune disorders, and rare genetic diseases.

Recent advancements have broadened the therapeutic applications of biologics. For instance, in December 2024, the U.S. Food and Drug Administration approved Nemluvio (nemolizumab-ilto), an IL-31 inhibitor biologic developed by Galderma, for individuals aged 12 and older with moderate to severe atopic dermatitis. This approval introduces a new option for managing this chronic skin condition.

What Questions Should You Ask before Buying a Market Research Report?

• How is the biologics market evolving?
• What is driving and restraining the biologics market?
• How will each biologics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
• How will the market shares for each biologics submarket develop from 2025 to 2035?
• What will be the main driver for the overall market from 2025 to 2035?
• Will leading biologics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
• Who are the leading players and what are their prospects over the forecast period?
• What are the biologics projects for these leading companies?
• How will the industry evolve during the period between 2025 and 2035? What are the implications of biologics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the biologics market?
• Where is the biologics market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the biologics market today, and over the next 10 years:

• Our 367-page report provides 136 tables and 228 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2035 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising biologics prices and recent developments.

Segments Covered in the Report

Product

• Monoclonal Antibodies
  Human
  
  Humanized
  
  Chimeric
  
  Murine
• Vaccines
• Recombinant Proteins
• Regenerative Medicine
  Tissue Engineered Products
  
  Cell Therapy
  
  Gene Therapies
• Others

Application

• Oncology
• Infectious Diseases
• Autoimmune Disease
• Haematological Disorder
• Cardiovascular Disorders
• Others

Manufacturing Type

• Outsource
• In-house

Source

• Mammalian
• Microbial
• Others

End-users

• Hospitals
• Speciality Centres
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• South-East Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America

MEA

• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Biologics Market, 2025 to 2035, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

• AbbVie Inc.
• Amgen Inc.
• AstraZeneca plc
• Biogen Inc.
• Bristol-Myers Squibb Company
• Celltrion, Inc.
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences, Inc.
• Johnson & Johnson
• Merck & Co.
• Novo Nordisk A/S
• Pfizer Inc.
• Regeneron Pharmaceuticals, Inc.
• Sanofi

Overall world revenue for Biologics Market, 2025 to 2035 in terms of value the market will surpass US$450.0 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Biologics Market, 2025 to 2035 report help you?

In summary, our 360+ page report provides you with the following knowledge:

• Revenue forecasts to 2035 for Biologics Market, 2025 to 2035, with forecasts for product, application, manufacturing type, source, and end-users, each forecast at a global and regional level – discover the industry's prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2035 for five regional and 24 key national markets – See forecasts for the Biologics Market, 2025 to 2035 in North America, Europe, Asia Pacific, Latin America, and MEA. Also forecasted is the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 16 of the major companies involved in the Biologics Market, 2025 to 2035.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.